Hepion Pharmaceuticals Inc

NASDAQ:HEPA

10.80

-0.84 (-7.22%)

7:45:59 PM EDT: $10.60 -0.20 (-1.85%)

Hepion Pharmaceuticals Inc Stock, NASDAQ:HEPA

399 Thornall Street, 1st Floor, Edison, New Jersey 08837

United States of America

Phone: +1.732.902.4000

Number of Employees: 25

http://www.hepionpharma.com

Description

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.